Carmona Jose has filed 5 insider transactions across 1 company since December 2024.
Most recent transaction: a grant/award of 271600 shares of ADC Therapeutics SA ($ADCT) on February 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Carmona Jose | Chief Financial Officer | A | Common Shares | 271600 | $3.99 | 760,256.0000 | 136,446,534 | 55.58% | 0.20% |
| Feb. 13, 2026 | ADC Therapeutics SA | $ADCT | Carmona Jose | Chief Financial Officer | F | Common Shares | 25880 | $3.99 | 734,376.0000 | 136,446,534 | 3.40% | 0.02% |
| Dec. 6, 2025 | ADC Therapeutics SA | $ADCT | Carmona Jose | Chief Financial Officer | F | Common Shares | 53236 | $3.29 | 488,656.0000 | 136,446,534 | 9.82% | 0.04% |
| Feb. 13, 2025 | ADC Therapeutics SA | $ADCT | Carmona Jose | Chief Financial Officer | A | Common Shares | 240000 | $1.61 | 541,892.0000 | 97,159,966 | 79.50% | 0.25% |
| Dec. 6, 2024 | ADC Therapeutics SA | $ADCT | Carmona Jose | Chief Financial Officer | F | Common Shares | 48108 | $3.13 | 301,892.0000 | 104,824,877 | 13.75% | 0.05% |